DRIO DarioHealth Corp: שולי רווח נקי

סמל מסחרי של DarioHealth Corp (DRIO)

DarioHealth Corp. (DRIO) solutions for hypertension and diabetes control are largely decoupled from economic trends, as confirmed by the GURU.Markets aggregate chart. Net marginal sales revenue exhibits a trend where the -193.10 parameter determines the metric's magnitude. However, customer acquisition costs and cyber risks create uncertainty regarding the timeline to profitability. The company is actively scaling its digital therapeutics platform utilizing AI analytics.

DRIO: רווחיות נקייה של החברה DarioHealth Inc 04.07.2022 - 19.11.2026

DarioHealth Corporation (DRIO) - פילוחי מדדים ודוחות פיננסיים

- שער מניה ותחזית מחירי מומחים:
- נתוני שווי מניות החברה:
ניתוח בסיסי של החברה:DarioHealth Corp.
מוצרים מוגמרים של DarioHealth Corp

The efficiency of DarioHealth Corp. (DRIO) digital therapy is directly reflected in its net profit margin dynamics. This metric measures the share of final profit relative to total revenue after deducting all expenses. By analyzing the return on sales, an investor assesses the AI platform's ability to generate real cash flow. An increase in this indicator confirms the scalability of diabetes management services, while a downward trend signals excessive expansion costs.